NO20010456D0 - Triazolopyridiner for behandling av trombose-problemer - Google Patents

Triazolopyridiner for behandling av trombose-problemer

Info

Publication number
NO20010456D0
NO20010456D0 NO20010456A NO20010456A NO20010456D0 NO 20010456 D0 NO20010456 D0 NO 20010456D0 NO 20010456 A NO20010456 A NO 20010456A NO 20010456 A NO20010456 A NO 20010456A NO 20010456 D0 NO20010456 D0 NO 20010456D0
Authority
NO
Norway
Prior art keywords
triazolopyridines
treatment
thrombosis
thrombosis problems
Prior art date
Application number
NO20010456A
Other languages
English (en)
Other versions
NO20010456L (no
Inventor
William J Hoekstra
Edward C Lawson
Bruce E Maryanoff
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of NO20010456D0 publication Critical patent/NO20010456D0/no
Publication of NO20010456L publication Critical patent/NO20010456L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20010456A 1998-07-27 2001-01-26 Triazolopyridiner for behandling av trombose lidelser NO20010456L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9423198P 1998-07-27 1998-07-27
US09/354,032 US6303625B1 (en) 1998-07-27 1999-07-15 Triazolopyridines for the treatment of thrombosis disorders
PCT/US1999/016572 WO2000006570A1 (en) 1998-07-27 1999-07-21 Triazolopyridines for the treatment of thrombosis disorders

Publications (2)

Publication Number Publication Date
NO20010456D0 true NO20010456D0 (no) 2001-01-26
NO20010456L NO20010456L (no) 2001-03-26

Family

ID=22243910

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010456A NO20010456L (no) 1998-07-27 2001-01-26 Triazolopyridiner for behandling av trombose lidelser

Country Status (21)

Country Link
US (1) US6303625B1 (no)
EP (1) EP1102766B1 (no)
JP (1) JP2003527306A (no)
KR (1) KR20010079576A (no)
CN (1) CN1320125A (no)
AR (1) AR019477A1 (no)
AT (1) ATE263169T1 (no)
AU (1) AU757512B2 (no)
BR (1) BR9912556A (no)
CA (1) CA2338654A1 (no)
CZ (1) CZ2001347A3 (no)
DE (1) DE69916073T2 (no)
ES (1) ES2219042T3 (no)
HU (1) HUP0103832A3 (no)
ID (1) ID27214A (no)
MX (1) MXPA01001099A (no)
NO (1) NO20010456L (no)
PL (1) PL345769A1 (no)
SK (1) SK1342001A3 (no)
WO (1) WO2000006570A1 (no)
ZA (1) ZA200100783B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6306909B1 (en) 1997-03-12 2001-10-23 Queen's University At Kingston Anti-epileptogenic agents
ES2270868T3 (es) * 1999-08-13 2007-04-16 Biogen Idec Ma Inc. Inhibidores de la adhesion celular.
TWI290136B (en) * 2000-04-05 2007-11-21 Daiichi Seiyaku Co Ethylenediamine derivatives
CA2448160A1 (en) * 2001-05-25 2002-12-05 Queen's University At Kingston Heterocyclic beta-amino acids and their use as anti-epileptogenic agents
US7365205B2 (en) 2001-06-20 2008-04-29 Daiichi Sankyo Company, Limited Diamine derivatives
BRPI0514391A (pt) * 2004-08-18 2008-06-10 Pharmacia & Upjohn Co Llc compostos de triazolopiridina para o tratamento de inflamação
US7618983B2 (en) * 2004-11-10 2009-11-17 Janssen Pharmaceutica, N.V. Bicyclic triazole α4 integrin inhibitors
CA2621640C (en) * 2005-09-16 2013-10-29 Daiichi Sankyo Company, Limited Optically active diamine derivative and process for producing the same
WO2008045393A2 (en) * 2006-10-11 2008-04-17 Amgen Inc. Imidazo- and triazolo-pyridine compounds and methods of use therof
WO2010117926A1 (en) * 2009-04-07 2010-10-14 Schering Corporation Substituted triazolopyridines and analogs thereof
US8871760B2 (en) * 2009-09-21 2014-10-28 Roche Palo Alto Llc [1,2,4]triazolo[3,4-C][1,4]oxazines as P2X7 modulators
CA2848809A1 (en) 2011-09-15 2013-03-21 Novartis Ag 6-substituted 3-(quinolin-6-ylthio)-[1,2,4]triazolo[4,3-a]pyradines as c-met tyrosine kinase
JP2016520113A (ja) * 2013-06-03 2016-07-11 バイエル ファーマ アクチエンゲゼルシャフト 血栓塞栓疾患の治療のためのトロンビン阻害薬としてのトリアゾロピリジン類
GB201511382D0 (en) 2015-06-29 2015-08-12 Imp Innovations Ltd Novel compounds and their use in therapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3050525A (en) 1960-12-14 1962-08-21 John B Bicking Certain derivatives of s-triazolo [4, 3-a]-pyridine
CN1118139A (zh) 1993-02-22 1996-03-06 麦克公司 纤维蛋白原受体拮抗剂
DE4326758A1 (de) * 1993-08-10 1995-02-16 Basf Ag [1,3,4]Triazolo[1,5-a]pyridine
CA2134192A1 (en) 1993-11-12 1995-05-13 Michael L. Denney 5, 6-bicyclic glycoprotein iib/iiia antagonists

Also Published As

Publication number Publication date
HUP0103832A2 (hu) 2002-04-29
NO20010456L (no) 2001-03-26
ZA200100783B (en) 2002-01-28
CZ2001347A3 (cs) 2001-12-12
SK1342001A3 (en) 2002-04-04
JP2003527306A (ja) 2003-09-16
BR9912556A (pt) 2002-01-15
AU5221899A (en) 2000-02-21
CA2338654A1 (en) 2000-02-10
EP1102766B1 (en) 2004-03-31
ID27214A (id) 2001-03-08
CN1320125A (zh) 2001-10-31
KR20010079576A (ko) 2001-08-22
WO2000006570A1 (en) 2000-02-10
AR019477A1 (es) 2002-02-20
EP1102766A1 (en) 2001-05-30
MXPA01001099A (es) 2002-04-24
PL345769A1 (en) 2002-01-02
AU757512B2 (en) 2003-02-20
DE69916073T2 (de) 2004-12-30
ES2219042T3 (es) 2004-11-16
HUP0103832A3 (en) 2002-12-28
ATE263169T1 (de) 2004-04-15
US6303625B1 (en) 2001-10-16
DE69916073D1 (de) 2004-05-06

Similar Documents

Publication Publication Date Title
NO983284D0 (no) Antikoagolante midler egnet i behandling av trombose
DE29816175U1 (de) Wasserbehandlungseinrichtung
NO974554L (no) FremgangsmÕte for behandling av en underjordisk formasjon
FI20000863A (fi) Uusi hoitomenetelmä
ID30339A (id) Metode pengobatan baru
NO20003042D0 (no) FremgangsmÕte for profylaktisk behandling av mastitt
NO20010456D0 (no) Triazolopyridiner for behandling av trombose-problemer
IS4789A (is) Meðferðarefnasambönd
NO20003454L (no) FremgangsmÕte for fremstilling av (-)cis-3-hydroksy-1-metyl-4-
ID19542A (id) Pengobatan baru
FI980222A0 (fi) Stycke av isoleringsaemne med en genomgaoende primaerstroemledning
NO20003481D0 (no) FremgangsmÕte for behandling av COPD
NO993549L (no) Imino-aza-antracyklinonderivater til behandling av amyloidosis
NO20002481D0 (no) Kombinasjonsterapi for behandling av AIDS
DE29823166U1 (de) Massageeinrichtung
DE69912763D1 (de) Behandlungsanlage
NO20006383L (no) Fremgangsmåte for behandling
NO962812D0 (no) Fremgangsmåte for behandling av nervebetennelse
NO996166L (no) FremgangsmÕte for behandling av avluter
NO984190D0 (no) Fremgangsmåte for behandling av insomnia
NO20011268D0 (no) Forbindelse til behandling av depresjon
IL141129A0 (en) Triazolopyridines for the treatment of thrombosis disorders
DK199800272U3 (da) Renseanlæg
DK82798A (da) Treatment of GABA-uptake related disorders
FI980433A0 (fi) Foerfarande foer utnyttjande i samband med tillslutandet av en vaetskefoerpackning

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application